Acrivon Therapeutics Inc
(ACRV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 09-2021 | 12-2020 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | N/A | 0 | 1,583 |
| Other current assets | 0 | 0 | 136 |
| TOTAL | $N/A | $0 | $1,719 |
| Non-Current Assets | |||
| PPE Net | N/A | N/A | 78 |
| Other Non-Current Assets | 0 | 0 | 407 |
| TOTAL | $N/A | $N/A | $485 |
| Total Assets | $N/A | $0 | $2,185 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 0 | 0 | 136 |
| Accrued Expenses | N/A | 0 | 477 |
| TOTAL | $N/A | $0 | $613 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 0 | 0 | 318 |
| TOTAL | $N/A | $N/A | $318 |
| Total Liabilities | $N/A | $0 | $931 |
| Shareholders' Equity | |||
| Common Shares | N/A | 0 | 1 |
| Retained earnings | N/A | 0 | -8,622 |
| Other shareholders' equity | 0 | 0 | 9,667 |
| TOTAL | $N/A | $0 | $1,254 |
| Total Liabilities And Equity | $0 | $0 | $2,185 |